Protagonist Therapeutics
PTGX
PTGX
239 hedge funds and large institutions have $2.78B invested in Protagonist Therapeutics in 2024 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 78 increasing their positions, 64 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
239
Holders Change
+51
Holders Change %
+27.13%
% of All Funds
3.46%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
77
Increased
78
Reduced
64
Closed
24
Calls
$2.44M
Puts
$5.15M
Net Calls
-$2.72M
Net Calls Change
+$3.89M
Top Buyers
| 1 |
BlackRock
New York
|
$460M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
$78M |
| 3 |
State Street
Boston,
Massachusetts
|
$143M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$190M |
| 5 |
Invesco
Atlanta,
Georgia
|
$29.4M |
